Innovative drugs at the 21th century
https://doi.org/10.18093/0869-0189-2015-25-6-645-648
Abstract
Currently, new drugs have being developed with a conceptually new research design based on human genome findings. Mainly, new drugs are intend ed for treatment of chronic noninfectious diseases, primarily, cardiovascular diseases, malignancies and respiratory diseases. One of the fundamental research directions is searching for target molecules including lipid metabolism regulators, anticoagulants, fibrinolytics, and monoclonal antibodies. The former are considered as target therapy in cardiology, dermatology, oncology, rheumatology, allergology, pulmonology, ophthalmology, etc. Another important direction is development of orphan drugs. Further basic knowledge is needed for development of new drug generations.
About the Author
A. G. Chuchalin
Federal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia: 32, build. 4, 11th Parkovaya str., Moscow, 105077, Russia
Russian Federation
Russian Federation
MD, Professor, Academician of Russian Science Academy, Director of Federal Institution «Pulmonology Research Institute», Federal Medical and Biological Agency of Russia; Head of Department of of Hospital Internal Medicine. Pediatric Faculty, State Institution «N.I.Pirogov Russian National Research Medical University», Healthcare Ministry of Russia; President of Russian Respiratory Society; Chief Therapeutist and Pulmonologist of Healthcare Ministry of Russia; tel. / fax: (495) 4655264
Review
For citations:
Chuchalin A.G. Innovative drugs at the 21th century. PULMONOLOGIYA. 2015;25(6):645-648. (In Russ.) https://doi.org/10.18093/0869-0189-2015-25-6-645-648
Views:
1526
Email this article 